2021
DOI: 10.1007/s10989-020-10155-y
|View full text |Cite
|
Sign up to set email alerts
|

MA-[D-Leu-4)-OB3, a Small Molecule Synthetic Peptide Leptin Mimetic, Improves Serum Lipid Profiles in Mouse Models of Type 1 and Type 2 Diabetes Mellitus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…Most recently, the prophylactic capacity of MA-[D-Leu-4]-OB3 to prevent or slow the progression of obesity, insulin resistance, and cognitive impairment in a mouse model of T2DM has been reported (Chua et al, 2021). The ability of MA-[D-Leu-4]-OB3 to improve serum lipid profiles in mouse models of T1DM and T2DM (Hirschstein et al, 2021), suggests an additional application targeted toward reducing the risk of adverse cardiovascular events in humans that are associated with both T1DM and T2DM.…”
Section: Assessing the Effects Of Leptin Mimetics On Cognitive Functionmentioning
confidence: 99%
“…Most recently, the prophylactic capacity of MA-[D-Leu-4]-OB3 to prevent or slow the progression of obesity, insulin resistance, and cognitive impairment in a mouse model of T2DM has been reported (Chua et al, 2021). The ability of MA-[D-Leu-4]-OB3 to improve serum lipid profiles in mouse models of T1DM and T2DM (Hirschstein et al, 2021), suggests an additional application targeted toward reducing the risk of adverse cardiovascular events in humans that are associated with both T1DM and T2DM.…”
Section: Assessing the Effects Of Leptin Mimetics On Cognitive Functionmentioning
confidence: 99%